agilon health, inc. (NYSE:AGL - Get Free Report)'s stock price traded down 7.9% during mid-day trading on Tuesday after Stifel Nicolaus lowered their price target on the stock from $7.00 to $2.00. Stifel Nicolaus currently has a hold rating on the stock. agilon health traded as low as $1.99 and last traded at $1.99. 1,089,524 shares changed hands during trading, a decline of 78% from the average session volume of 4,947,120 shares. The stock had previously closed at $2.16.
A number of other equities research analysts have also recently commented on the company. JMP Securities cut agilon health from an "outperform" rating to a "market perform" rating in a report on Monday. Deutsche Bank Aktiengesellschaft lowered their price target on agilon health from $5.00 to $4.00 and set a "hold" rating on the stock in a report on Friday, August 9th. Barclays cut their price objective on shares of agilon health from $5.00 to $2.00 and set an "underweight" rating for the company in a report on Monday. Benchmark reissued a "buy" rating and issued a $9.00 target price on shares of agilon health in a report on Thursday, August 8th. Finally, Bank of America lowered shares of agilon health from a "buy" rating to an "underperform" rating and set a $3.00 target price for the company. in a research report on Wednesday, October 2nd. Three investment analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat, agilon health presently has a consensus rating of "Hold" and a consensus target price of $7.03.
Check Out Our Latest Stock Analysis on agilon health
Insider Activity at agilon health
In related news, CEO Steven Sell purchased 20,000 shares of the business's stock in a transaction dated Thursday, September 12th. The shares were purchased at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the acquisition, the chief executive officer now owns 67,590 shares in the company, valued at approximately $227,102.40. This trade represents a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. 3.20% of the stock is currently owned by insiders.
Institutional Trading of agilon health
A number of large investors have recently modified their holdings of AGL. Quantbot Technologies LP bought a new stake in shares of agilon health in the first quarter valued at about $862,000. Swiss National Bank lifted its position in shares of agilon health by 0.6% in the 1st quarter. Swiss National Bank now owns 602,800 shares of the company's stock worth $3,677,000 after purchasing an additional 3,400 shares during the period. Bleakley Financial Group LLC bought a new position in shares of agilon health during the first quarter valued at approximately $65,000. Blair William & Co. IL increased its holdings in agilon health by 8.3% during the first quarter. Blair William & Co. IL now owns 242,076 shares of the company's stock valued at $1,477,000 after buying an additional 18,599 shares during the period. Finally, Vanguard Group Inc. raised its stake in agilon health by 1.3% in the first quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company's stock worth $176,582,000 after buying an additional 371,537 shares in the last quarter.
agilon health Stock Performance
The company has a debt-to-equity ratio of 0.04, a current ratio of 1.36 and a quick ratio of 1.36. The company has a market cap of $767.41 million, a PE ratio of -1.99 and a beta of 0.60. The business has a fifty day simple moving average of $3.22 and a two-hundred day simple moving average of $4.95.
agilon health (NYSE:AGL - Get Free Report) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 46.06% and a negative net margin of 6.88%. The company had revenue of $1.45 billion for the quarter, compared to analysts' expectations of $1.47 billion. During the same quarter last year, the company earned ($0.06) earnings per share. Research analysts anticipate that agilon health, inc. will post -0.32 earnings per share for the current year.
agilon health Company Profile
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Further Reading
Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
